Clinical Trial Update: FUSA With Intratumoral PolyICLC in Regionally Advanced Resectable Melanoma [EARLY_Phase 1]

View source ↗

Summary

A clinical trial update indicates a study of FUSA with intratumoral PolyICLC for regionally advanced resectable melanoma is in early Phase 1 and currently recru…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Melanoma

Drugs mentioned

• FUSA
• PolyICLC (poly-ICLC)

Snippet

Sponsor: University of Virginia | Conditions: Advanced Melanoma | EARLY_Phase 1 | Status: RECRUITING